Alterola Biotech Inc
Business Description
We acquired intellectual property relating to certain chewing gum compositions
having appetite suppressant activity (the “IP”). Following the acquisition
of the IP, we commenced pursuing the development of chewing gums for the delivery
of nutraceutical/functional ingredients for applications such as appetite suppressant,
cholesterol suppressant, vitamin delivery, antioxidant delivery and motion sickness
suppressant.
|